Cargando…
nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma
The role of the nm23 gene in human ovarian cancer is still controversial. We studied the expression of the nm23-H1 gene in 247 human epithelial ovarian carcinomas. The patients were followed-up until their death, or for a minimum of 5 years if they survived. The expression of the gene was studied by...
Autores principales: | Schneider, J, Pollán, M, Jiménez, E, Marenbach, K, Martínez, N, Volm, M, Marx, D, Meden, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374504/ https://www.ncbi.nlm.nih.gov/pubmed/10817501 http://dx.doi.org/10.1054/bjoc.2000.1116 |
Ejemplares similares
-
hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer
por: Ercoli, A, et al.
Publicado: (1999) -
The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma
por: Iizuka, N, et al.
Publicado: (1999) -
Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.
por: Mandai, M., et al.
Publicado: (1995) -
Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.
por: Watanabe, J., et al.
Publicado: (1995) -
Expression of nm23‐Hl and nm23‐H2 Proteins in Prostate Carcinoma
por: Konishi, Noboru, et al.
Publicado: (1993)